| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide methods for involving an avoidance of harmful drug interactions between fluvoxamine and pirfenidone or some other moderate-to-powerful inhibitor of CYP enzyme. <P>SOLUTION: Provided are improved use and method for administrating pirfenidone to a patient generally requiring a pirfenidone therapy, and a method for preparing or wrapping piefenidone formulations, container, package, and kit. <P>COPYRIGHT: (C)2013,JPO&INPIT |
